Summary:
The study drug is being tested to see if it is safe and helps reduce symptoms of depression when compared to placebo in people with depression who only partially respond to treatment with SSRI or SNRI medication.
Qualified Participants Must:
• Be between 18 and 65 years of age
•
Suffer from Major Depression
•
Currently be taking no more than one anti-depressant
•
Not be responding to your current antidepressant treatment
Qualified Participants May Receive:
Compensation for time and travel.